NOVERA RETATRUTIDE VS. HYALGAN DUROLANE : A THOROUGH EXAMINATION

Considering both Novo Nordisk Retatrutide and Intra-articular Durolane target joint soreness, their mechanisms of action are considerably different . Retatrutide is a combined receptor affecting the GLP-1 receptor and the GIP receptor, primarily used for weight regulation, which can secondarily